ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
179 hedge funds and large institutions have $826M invested in Acorda Therapeutics in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 64 increasing their positions, 55 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $1.01B → $826M (-$189M)
Holders
179
Holding in Top 10
–
Calls
$38.5M
Puts
$15.2M
Top Buyers
| 1 | +$14.2M | |
| 2 | +$12.9M | |
| 3 | +$11.2M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.21M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$4.79M |
Top Sellers
| 1 | -$25.2M | |
| 2 | -$6.71M | |
| 3 | -$4.84M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.14M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.43M |